Amanta Healthcare Limited has announced changes in its senior management personnel structure, with the Board of Directors approving key appointments and removals effective February 10, 2026. The pharmaceutical company has formally communicated these changes to stock exchanges in compliance with regulatory requirements.

Board Approval and Regulatory Compliance

The Board of Directors of Amanta Healthcare Limited, acting on recommendations from the Nomination and Remuneration Committee, approved the senior management changes on February 10, 2026. The company has notified both BSE Limited (Scrip Code: 544502) and National Stock Exchange of India Limited (Trading Symbol: AMANTA) about these personnel changes pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Senior Management Personnel Changes

The company announced two significant changes to its senior management team:

Profile of New Senior Management Personnel

Shri Urmil Oza brings substantial experience and expertise to his role as Senior Management Personnel. His professional background includes:

Key Responsibilities and Expertise

Urmil Oza's extensive experience encompasses multiple critical areas within the organization:

• Production Engineering: Leading production engineering operations and utility equipment management
• Project Management: Overseeing project activities and technical procurement processes
• Vendor Relations: Managing all plant and utility side vendor communications
• Equipment Management: Handling utility and plant equipment maintenance and operational management on a routine basis
• Regulatory Compliance: Managing all government-related documentation and compliance requirements

Corporate Governance

The announcement was signed by Nikhita Dinodia, Company Secretary and Compliance Officer (Membership No. 53362), ensuring proper corporate governance protocols. The company has requested both stock exchanges to take note of these changes in their records, maintaining transparency with stakeholders and regulatory bodies.

Amanta Healthcare Limited has announced the opening of a special window for transfer and dematerialisation of physical securities, in compliance with recent SEBI regulations. The initiative provides investors with an opportunity to complete previously unsuccessful transfer processes for securities transactions that occurred before April 01, 2019.

SEBI Circular Implementation

The special window has been established pursuant to SEBI Circular no. HO/38/13/11(2)2026-MIRSD-POD/ 1/3750/2026 dated January 30, 2026. This regulatory directive mandates the opening of a special facility for transfer and dematerialisation of physical securities that were previously rejected, returned, or not processed due to various deficiencies in documentation or procedural requirements.

Window Duration and Scope

The one-year window provides investors with sufficient time to gather necessary documentation and complete the transfer and dematerialisation process for their physical securities.

Investor Process and Requirements

Investors who wish to utilise this special window may re-lodge their transfer deeds along with all necessary supporting documents. All submissions must be complete in all respects and should be directed to the company's designated Registrar and Transfer Agent. The company emphasises that documentation must meet all regulatory requirements to ensure successful processing.

Registrar and Transfer Agent Details

Information Accessibility

Amanta Healthcare has ensured comprehensive information dissemination regarding this special window. The company has hosted detailed information on its official website at https://www.amanta.co.in/investors for easy investor access. Additionally, investors can access the complete SEBI circular through the official SEBI website for detailed regulatory guidelines and requirements.

The company's proactive communication demonstrates its commitment to facilitating investor convenience and regulatory compliance, ensuring that all eligible investors are aware of this opportunity to complete their pending transfer and dematerialisation processes.